Novel (4-Phenylpiperidinyl)- and (4-Phenylpiperazinyl)alkyl-Spaced Esters of 1-Phenylcyclopentanecarboxylic Acids as Potent σ-Selective Compounds

Journal of Medicinal Chemistry

Volumn 37, Issue 13, 1994, Pages 1964-1970

  Hudkins, Robert L ^a,b,c   Mailman, Richard B ^a,b,c   DeHaven Hudkins, Diane L ^a,b,c,d  

^a Albany Molecular Research Institute   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c EASTMAN KODAK COMPANY   (United States)

^d Sterling Winthrop Pharmaceut R   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 NITROPHENYL)CYCLOPENTANECARBOXYLIC ACID 2 (4 PHENYL 1 PIPERIDINYL)ETHYL ESTER; 1 (4 NITROPHENYL)CYCLOPENTANECARBOXYLIC ACID 2 (4 PHENYL 1 PIPERIDYL)ETHYL ESTER; 4 PHENYLPIPERIDINE DERIVATIVE; DOPAMINE RECEPTOR; MUSCARINIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SIGMA OPIATE RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; DOPAMINERGIC SYSTEM; DRUG BINDING SITE; PSYCHOSIS;

ANIMAL; BINDING SITES; BRAIN; CYCLOPENTANES; GUINEA PIGS; MOLECULAR WEIGHT; PIPERAZINES; PIPERIDINES; RADIOLIGAND ASSAY; RECEPTORS, DOPAMINE; RECEPTORS, MUSCARINIC; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, OPIOID; RECEPTORS, PHENCYCLIDINE; RECEPTORS, SIGMA;

EID: 0028064950     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm00039a008     Document Type: Article

References (54)

1. Walker, J. M.; Bowen, W. D.; Walker, F. O.; Matsumoto, R. R.; deCoeta, B. R.; Rice, K. C. Sigma receptors: Biology and function. Pharmacol. Rev. 1990, 42, 355-402.
2. Deutsch, S. I.; Weizman, A.; Goldman, M. E.; Morihisa, J. M. The sigma receptor: A novel site implicated in psychosis and antipsychotic drug efficacy. Clin. Neuropharmacol. 1988, 11, 105-119.
3. Largent, B. L.; Wikstrom, H.; Gundlach, A. L.; Snyder, S. H. Structural determinants of a receptor affinity. Mol. Pharmacol. 1987, 32, 772-784.
4. Snyder, S. H.; Largent, B. L. Receptor mechanisms in antipsychotic drug action. Focus on sigma receptors. J. Neuropsychiatry 1989, 1, 7-15.
5. Tam, S. W.; Cook, L. Sigma opiates and certain antipsychotic drugs mutually displace (+)-[8H]SKF-10,047 and [3H] haloperidol binding in guinea pig brain membranes. Proc. Natl. Acad. Sci. U.S.A. 1984, 81, 5618-6621.
6. Tam, S. W.; Zhang, A. Z. and PCP receptors in human frontal cortex membranes. Eur. J. Pharmacol. 1988,154, 343-344.
7. Tam, S. W.; Gilligan, P. J. Sigma receptor ligands. Curr. Opin. Invest. Drugs 1993, 2, 295-303.
8. Rao, T. S.; Cler, J. A.; Mick, S. J.; Dilworth, V. M.; Contreras, P. C.; Iyengar, S.; Wood, P. L. Neurochemical characterization of dopaminergic effects of opipramol, a potent sigma receptor ligand, in vivo. Neuropharmacology 1990, 29, 1191-1197.
9. Graybiel, A. M.; Besson, M. J.; Weber, E. Neuroleptic-sensitive binding sites in the nigrostriatal system: Evidence for differential distribution of sigma sites in the substantia nigra, pars compacta of the cat. J. Neurosci. 1989, 9, 326-338.
10. Largent, B. L.; Gundlach, A. L.; Snyder, S. H. Psychotomimetic opiate receptors labeled and visualized with (+)-[3H]3-(3-hydrozyphenyl)-N-(l-propyl)piperidine. Proc. Natl. Acad. Sci. U.S.A. 1984, 81, 4983-4987.
11. Taylor, D. P.; Dekleva, J. Potential antipsychotic BMY-14802 selectively binds sigma sites. Drug Dev. Res. 1987,11, 65-70.
12. Wachtel, S. R.; White, F. J. Electrophysiological effects of BMY14802, a new potential antipsychotic drug, on midbrain dopamine neurons in the rat: Acute and chronic studies. J. Pharmacol. Exp. Ther. 1988, 244, 410-416.
13. Ceci, A.; Smith, M.; French, E. D. Activation of the Ai0 mesolimbic system by the receptor agonist (+)-SKF10047 can be blocked by rimcazole, a novel putative antipsychotic. Eur. J. Pharmacol. 1988, 154, 53-57.
14. Steinfels, G. F.; Tam, S. W. Selective a receptor agonist and antagonist affect dopamine neuronal activity. Eur. J. Pharmacol. 1989, 163, 167-170.
15. Gilligan, P. J.; Cain, G. A.; Christos, T. E.; Cook, L.; Drummond, S.; Johnson, A.L.; Kergaye, A. A.; McElroy, J. F.; Rohrbach, K. W.; Schmidt, W. K.; Tam, S.W. Novel piperidine a receptor ligands as potential antipsychotic drugs. J. Med. Chem. 1992, 35, 4344-4361.
16. Contreras, P. C.; Gray, N. M.; Ragan, D. M.; Lanthorn, T. H. BMY-14802 protects against ischemia-induced neuronal damage in the gerbil. Life Sci. 1992, 51, 1145-1149.
17. Carter, C. J.; Lloyd, K. G.; Zivkovic, B.; Scatton, B. Ifenprodil and SL 82.0715 as cerebral antiischemic agents. III. Evidence for antagonistic effects at the polyamine modulatory site within the N-methyl-D-aspartate receptor complex. J. Pharmacol. Exp. Ther. 1989, 253, 475-482.
18. Prince, D. A.; Feeser, H. R. Dextromethorphan protects against cerebral infarction in a rat model of hypoxia-ischemia. Neurosci. Lett. 1988, 85, 291-296.
19. Contreras, P. C.; Ragan, D. M.; Bremer, M. E.; Lanthorn, T. H.; Gray, N. M.; Iyengar, S.; Jacobson, A. E.; Rice, K. C.; deCosta, B. R. Evaluation of U50.488H analogs for antiischemic activity in the gerbil. Brain Res. 1991, 546, 79-82.
20. Rao, T. S.; Cler, J. A.; Mick, S. J.; Ragan, D. M.; Lanthorn, T. H.; Contreras, P.C.; Iyengar, S.; Wood, P. L. Opipramol, a potent sigma ligand, is an anti-ischemic agent: Neurochemical evidence for an interaction with the N-methyl-D-aspartate receptor complex in vivo by cerebellar cGMP measurements. Neuropharmacology 1990, 29, 1199-1204.
21. Pontecorvo, M. J.; Karbon, E. W.; Goode, S.; Clissold, D. B.; Borosky, S. A.; Patch, R. J.; Ferkany, J. W. Possible cerebroprotective and in vivo NMDA antagonist activities of sigma agents. Brain Res. Bull. 1991, 26, 461-465.
22. Karbon, E. W.; Patch, R. J.; Pontecorvo, M. J.; Ferkany, J. W. Ifenprodil potently interacts with [3H] (+)-3-PPP-labeled a binding sites in guinea pig brain membranes. Eur. J. Pharmacol. 1990, 176, 247-248.
23. Gotti, B.; Duverger, D.; Bertin, J.; Carter, C.; Dupont, R.; Frost, J.; Gaudilliere, B.; MacKenzie, E. T.; Rousseau, J.; Scatton, B.; Wick, A. Ifenprodil and SL 82.0715as cerebral anti-ischemic agents. 1. Evidence for efficacy in models of focal cerebral ischemia. J. Pharmacol. Exp. Ther. 1988, 247, 1211-1221.
24. DeHaven-Hudkins, D. L.; Fleissner, L. C.; Ford-Rice, F. Y. Characterization of the binding of [3H] (+)-pentazocine to recognition sites in guinea pig brain. Eur. J. Pharmacol. 1992, 227, 371-378.
25. Quirion, R.; Bowen, W. D.; Itzhak, Y.; Junién, J. L.; Musacchio, J. M.; Rothman, R. B.; Su, T. P.; Tam, S. W.; Taylor, D. P. A proposal for the classification of sigma binding sites. Trends Pharmacol. Sci. 1992, 13, 85-86.
26. Booth, R. G.; Wyrick, S. D.; Baldessarini, R. J.; Kula, N. S.; Myers, A. M.; Mailman, R. B. New-like receptor recognized by novel phenylaminotetralins: Ligand binding and functional studies. Mol. Pharmacol. 1993, 44, 1232-1239.
27. Hudkins, R. L.; DeHaven-Hudkins, D. L. Mi muscarinic antagonists interact with a recognition sites. Life Sci. 1991, 49, 1229-1235.
28. DeHaven-Hudkins, D. L.; Ford-Rice, F. Y.; Allen, J. T.; Hudkins, R. L. Allosteric modulation of ligand binding to [3H] (+)pentazocinedefined a recognition sites by phenytoin. Life Sci. 1993, 53, 41-48.
29. Hudkins, R. L.; DeHaven-Hudkins, D.L.; Stubbins, J. F. Muscarinic receptor binding profile of para-substituted caramiphen analogs. J. Med. Chem. 1991, 34, 2984-2989.
30. Hudkins, R. L.; Kachur, J. F.; Dewey, W. L.; DeHaven-Hudkins, D. L.; Stubbins, J. F. Antimuscarinic activity of a novel indane analog of aprophen and caramiphen. Med. Chem. Res. 1992, 2, 173-180.
31. Stubbins, J. F.; Glassco, W. S.; DeHaven-Hudkins, D. L.; Hudkins, R. L. Muscarinic Mi and Mz binding affinity of cyclic amine derivatives of caramiphen and dicyclomine. Med. Chem. Res. 1992, 2, 384-393.
32. Manallack, D. T.; Wong, M. G.; Costa, M.; Andrews, P. R.; Beart, P. M. Receptor site topographies for phencyclidine-like and a receptor drugs: Predictions from quantitative conformational electrostatic potential and radioreceptor analysis. Mol. Pharmacol. 1988, 34, 863-879.
33. Carroll, F. I.; Abraham, P.; Parham, K.; Bai, X.; Zhang, X.; Brine, G. A.; Mascarella, S. W.; Martin, B. R.; May, E. L.; Sauss, C.; DiPaolo, L.; Wallace, P.; Walker, J. M.; Bowen, W. D. Enantiomeric N-subetituted N-normetazocines: A comparative study of affinities at, PCP, and μ opioid receptors. J. Med. Chem. 1992, 35, 2812-2818.
34. Cerkovnikov, E.; Stem, P. Chemical constitution and antihistaminic action. 1.1-Mono-and 1,4-disubstituted derivatives of piperazine. Arhiv. Kem. 1946, 18, 12-36.
35. Leonard, N. J.; Musker, W. K. Unsaturated amines. XVI. An oxidative cyclization route to oxazolidines and tetrahydro-1,3-oxazines. J. Am. Chem. Soc. 1960, 82, 5148-5155.
36. Pelz, K.; Protiva, M. Neurotrope und psychotrope substanzen XIV. 3-(4-Phenylpiperidino)propylderivate. Collect. Czech. Chem. Commun. 1967, 32, 2840-2853.
37. Breelow, D. S.; Yost, R. S.; Walker, H. G.; Hauser, C. R. Synthesis of atabrine analogs having various aliphatic-substituents in the side chain. J. Am. Chem. Soc. 1944, 66,1921-1924.
38. Yevich, J. P.; Temple, D. L.; New, J. S.; Taylor, D. P.; Riblet, L. A. Buspirone analogues. 1. Structure-activity relationships in a series of A7-aryl-and heteroarylpiperazine derivatives. J. Med. Chem. 1983, 26, 194-203.
39. Manallack, D. T.; Beart, P. M. Quantitative conformational analyses predict distinct receptor sites for PCP-like and drugs. Eur. J. Pharmacol. 1987, 144, 231-235.
40. Glennon, R. A.; Smith, J. D.; Ismaiel, A. M.; El-Ashmawy, M.; Battaglia, G.; Fischer, J. B. Identification and exploitation of the-opiate pharmacophore. J. Med. Chem. 1991, 34, 1094-1098.
41. Ablordeppy, S. Y.; El-Ashmawy, M. B.; Glennon, R. A. Analysis of the structure-activity relationships of sigma receptor ligands. Med. Chem. Res. 1992, 1, 425-438.
42. Sircar, R.; Nichtenhauser, R.; Ieni, J. R.; Zukin, S. R. Characterization and autoradiographic visualization of (+)-[3H]SKF10,047 binding in rat and mouse brain: Further evidence for phencyclidine/*sigmaopiate” receptor commonality. J. Pharmacol. Exp. Ther. 1986, 237, 681-688.
43. Glennon, R. A.; Yousif, M. Y.; Ismaiel, A. M.; El-Ashmawy, M. B.; Herndon, J. L.; Fischer, J. B.; Server, A. C.; Howie, K. J. B. Novel 1-phenylpiperazine and 4-phenylpiperidine derivatives as highaffinity a ligands. J. Med. Chem. 1991, 34, 3360-3365.
44. Su, T.-P.; Wu, X. Z.; Cone, E. J.; Shukla, K.; Gund, T. M.; Dodge, A. L.; Parish, D. W. Sigma compounds derived from phencyclidine: Identification of PRE-084, a new, selective sigma ligand. J. Pharmacol. Exp. Ther. 1991, 259, 543-550.
45. Hudkins, R. L.; DeHaven-Hudkins, D. L. Structure-affinity relationships of caramiphen analogs. Unpublished results.
46. Burtner, R. R.; Cusic, J. W. Antispasmotics. I. Basic esters of some arylacetic acids. J. Am. Chem. Soc. 1943, 65, 262-267.
47. Biel, J. H.; Nuhfer, P. A.; Hoya, W. K.; Leiser, H. A.; Abood, L. G. Cholinergic blockade as an approach to the development of new psychotropic agents. Ann. N.Y. Acad. Sci. 1962, 96, 251-262.
48. Humber, L. G.; Bruderlein, F. T.; Philipp, A. H.; Gotz, M.; Voith, K. Mapping the dopamine receptor. 1. Features derived from modifications in ring E of the neuroleptic butaclamol. J. Med. Chem. 1979, 22, 761-767.
49. Philipp, A. H.; Humber, L. G.; Voith, K. Mapping the dopamine receptor. 2. Features derived from modifications in the rings A/B region of the neuroleptic butaclamol. J. Med. Chem. 1979, 22, 768-773.
50. Olson, G. L.; Cheung, H.-C.; Morgan, K. D.; Blount, J. F.; Todaro, L.; Berger, L.; Davidson, A. B.; Boff, E. A dopamine receptor model and its application in tiie design of a new class of rigid pyrrolo-[2,3-g] isoquinoline antipsychotics. J. Med. Chem. 1981, 24, 1026-1034.
51. Mottola, D. M.; Brewster, W. K.; Cook, L. L.; Nichols, D. E.; Mailman, R. B. Dihydrexidine, a novel full efficacy Di dopamine receptor agonist. J. Pharmacol. Exp. Ther. 1992, 262, 383-393.
52. Murphy, D. E.; Hutchison, A. J.; Hurt, S. D.; Williams, M.; Sills, M. A. Characterization of the binding of [3H]-CGS-19755: a novel N-methyl-D-aspartate antagonist with nanomolar affinity in rat brain. Br. J. Pharmacol. 1988, 95, 932-938.
53. Vignon, J.; Chicheportiche, R.; Chicheportiche, M.; Kamenka, J.-M.; Geneste, P.; Lazdunski, M. [3H]TCP: a new tool with high affinity for the PCP receptor in rat brain. Brain Res. 1983, 280, 194-197.
54. Pert, C. B.; Snyder, S. H. Opiate receptor binding of agonists and antagonists affected differentially by sodium. Mol. Pharmacol. 1974, 10, 868-879.